small molecule therapeutic pharmaceuticals for the treatment, alleviation and prevention of acute organ injuries and fibrotic diseases; pharmaceutical Read More

Classification Information

Class [005]
Small molecule therapeutic pharmaceuticals for the treatment, alleviation and prevention of acute organ injuries and fibrotic diseases; pharmaceutical and biological preparations for the treatment, alleviation and prevention of heart conditions, brain conditions, kidney conditions, and liver conditions; pharmaceutical and biological preparations for use in the treatment, alleviation and prevention of ischemic conditions; pharmaceutical and biological preparations for use in the treatment, alleviation and prevention of fibrosis; pharmaceutical and biological preparations for use in the treatment, alleviation and prevention of autoimmune diseases; pharmaceutical and biological preparations for use in the treatment, alleviation and prevention of delayed graft function and acute kidney injury

Classification kind code

Class [042]
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing a website featuring electronic publications related to scientific research on heart conditions, brain conditions, kidney conditions, and liver conditions; providing a website featuring electronic publications related to scientific research on ischemic conditions, fibrosis, autoimmune diseases, organ transplantation; providing a website featuring electronic publications related to scientific research on acute organ injuries

Classification kind code

Mark Details

Serial Number

2038420

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 23^rd Jul 2024	Search Recorded
Submitted for opposition 20 on 23^rd Jul 2024	Examiner's First Report
Submitted for opposition 287 on 10^th Jun 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 08^th Jul 2020	Filed
Submitted for opposition 1 on 08^th Jul 2020	Created
Submitted for opposition 31 on 08^th Jul 2020	Formalized